Articles by Editor

BEST Surgery & Therapies
CINCINNATI – November 15, 2022 – (Newswire.com)

…

NEW YORK – November 15, 2022 – (Newswire.com)

Cedar, an enterprise…

The company is now the first and only health insurance platform to provide complete coverage for ground-breaking, early diagnostic testing that includes artificial intelligence (AI)-powered analysis of brain imaging
…

Premier members can access special pricing of Arterys’ leading medical imaging platform and clinical AI workflow solutions

SAN FRANCISCO – November 15, 2022 – (Newswire.com)

Arterys, developer of the world’s first and market-leading internet platform for medical imaging, has been awarded a national group purchasing agreement for the Artificial Intelligence Solutions for Healthcare Category with Premier Inc. Effective Oct. 1, 2022, the new agreement allows Premier members, at their discretion, to take advantage of special pricing and terms pre-negotiated by Premier for Arterys’ medical imaging platform and clinical AI workflow solutions.

Arterys offers radiology departments a dedicated medical imaging platform with a comprehensive set of clinical AI-enhanced workflow solutions – adding value across a wide range of specialties. The platform delivers fast, accurate, and actionable medical imaging insights that empower physicians to make more informed treatment decisions and deliver better patient care. With its industry-leading FDA-cleared medical imaging applications and AI, Arterys provides customers with a high return on investment, combined with a low cost to implement and manage. 

“We are excited to offer Premier’s members access to the Arterys Medical Imaging AI Platform,” says John Axerio-Cilies, CEO and Co-Founder of Arterys. “As many members struggle with staffing, the Arterys platform allows for a second look, workflow improvements, and reduced IT overhead.”

Premier is a leading healthcare improvement company, uniting an alliance of approximately 4,400 U.S. hospitals and 250,000 other providers and organizations to transform healthcare. With integrated data and analytics, collaboratives, supply chain solutions, consulting, and other services, Premier enables better care and outcomes at a lower cost.

About Arterys:

Arterys, a Tempus Company, received the first-ever FDA Clearance of a DL/AI Model (Arterys Cardiac AI Model) and was the first developer of an internet platform for medical imaging. Driven by a vision to create a world where clinical care is data-driven and intelligent, Arterys provides fast, accurate, and actionable medical imaging insights that empower physicians to make more informed treatment decisions and deliver better patient care. With a single and seamless integration, Arterys offers radiology departments a dedicated medical imaging platform with a comprehensive set of clinical AI workflow solutions – adding value across a wide range of specialties. Arterys’ medical imaging platform, with industry-leading FDA-cleared medical imaging applications and AI, delivers customers a high return on investment, combined with a low cost to implement and manage. For more information on Arterys, please visit www.arterys.com.

Contact Information:

Mollie Schane

Head of Marketing

[email protected]

(650) 319-7230

Press Release Service
by
Newswire.com

Original Source:

Arterys Awarded Artificial Intelligence Solutions for Healthcare Agreement With Premier, Inc.

Company offers the fastest and only multi-touch sensing bionic hand on the market.

SAN DIEGO – November 14, 2022 – (Newswire.com)

Bionic technology company PSYONIC announced that it has launched a fundraising round on the crowdfunding website StartEngine. The round will support the ongoing development and delivery of its breakthrough bionic hand. It has raised more than $500,000 in its first two public weeks and is currently listed among the site’s most-funded companies.

Released nationally in 2021, PSYONIC’s Ability Hand^TM was called the a “miracle in the works” by CNBC earlier this year. 

The tough, lightweight Ability Hand is the only multi-touch sensing bionic hand on the market, and it closes faster than the blink of an eye – in about 200 milliseconds. It is made in the United States and is covered by Medicare, making it much more affordable and accessible than any other advanced bionic hand on the market.

Dr. Aadeel Akhtar, PSYONIC’s CEO, first encountered a person with a limb difference as a child visiting Pakistan with his parents. “She was my age, living in poverty, missing her right leg, and using a broken tree branch as a crutch. That’s what inspired me to want to go into this field and develop these advanced bionic limbs that would be affordable and accessible to others around the entire world.”

People throughout the United States – grandmothers and veterans, triathletes and teenagers – are already using the Ability Hand. (Watch them arm wrestle, flip a water bottle, and work on the farm.) PSYONIC is also exploring the development of a bionic leg, artificial tendons, new methods of providing sensory feedback, and software to improve biointegrated technologies’ functionality, responsiveness, and ease of use. 

Anyone over 18 can now buy shares of PSYONIC with a minimum investment of $250.

The bionic limb market is expected to grow to almost $3 billion in the next eight years, and PSYONIC’s Ability Hand is in high demand among robotics researchers as well. NASA, Meta, and Apptronik are clients.

“The Ability Hand’s anthropomorphic form factor with robust and feature-rich hardware offers an exciting and unique potential to use it as a platform for research in robot learning and dexterous manipulation,” said Mustafa Mukadam, Ph.D., who is working with the Ability Hand at Meta.

Levi Hargrove, Ph.D., director of the Center for Bionic Medicine at the Shirley Ryan Ability Lab, said, “The Ability Hand is an extremely capable device, even for our most advanced research studies. The PSYONIC team is responsive to our feedback, which makes it very easy to use with our intuitive and personalized control systems.” 

PSYONIC is a bionic technology company based in San Diego. Leveraging proprietary bionic breakthroughs, PSYONIC’s Ability Hand offers those with limb differences the high-performance solution they deserve. PSYONIC was founded by Dr. Aadeel Akhtar, who was one of MIT Technology Review’s top 35 Innovators Under 35 in 2021.

Contact Information:

Bill Bell

[email protected]

Press Release Service
by
Newswire.com

Original Source:

PSYONIC, Maker of ‘Miracle in the Works’ Bionic Hand, Launches Fundraising Round

The Covid-19 Detection Foundation (Dba Virufy) is the newest member of BARDA’S division of research, innovation, and ventures (DRIVe) medical countermeasures portfolio

SAN FRANCISCO – November 10, 2022 – (Newswire.com)

Lessons learned from the COVID-19 pandemic underscore the need for more rapidly scalable, low-cost, and broadly available approaches in responding to public health emergencies. Digital tools like smartphone or web-based applications present opportunities for new classes of medical countermeasures that could complement traditional approaches. Aiming for easy detection of Covid-19, Virufy has created an IA-based app that should make the diagnosis of the disease more inclusive.

Through AI/ML algorithms, smartphone and computer applications can use images and audio captured with the phone or computer’s existing hardware to assess aspects of a person’s health. Health-related image and audio recordings contain much more information than the human eye or ear alone can process, but AI/ML algorithms could be used to process that information, detect differences and patterns among images and sounds, and identify disease signatures. These digital tools could empower individuals with actionable information about their infection status or acute skin condition and symptoms so that they can self-isolate and seek medical care if appropriate.

Virufy is developing an app that uses a few seconds of cough audio, collected through a smartphone or computer microphone, to identify cough patterns indicative of a current COVID-19 infection. Virufy has demonstrated this capability based on an analysis of several thousand samples from international clinical networks and through crowdsourcing. With DRIVe’s support, Virufy will conduct additional clinical studies to refine and test their algorithm. Virufy will also initiate proof-of-concept work on AI algorithms to screen for other respiratory diseases based on cough audio.

VisualDx aims to create an AI/ML algorithm that analyzes user-provided skin lesion images together with a symptom questionnaire on a smartphone app. The algorithm can provide information on the indicated disease and other similarly presenting conditions. If successful, this project would demonstrate the power of AI/ML-based image analysis for easily and rapidly accessible symptom checking for potentially any pox-based virus such as smallpox or monkeypox, and provide a digital health solution that could be modified easily in a future outbreak.

BARDA’s 2022-2026 Strategic Plan emphasizes the importance of preparing for future public health emergencies by collaborating with innovators to develop medical countermeasures that can help save lives. Cutting-edge, digital guidance tools that can pivot and be brought to scale in response to new threats could aid in public health response. These DRIVe projects, if successful, could demonstrate the power of these tools to rapidly respond to other threats such as influenza and smallpox.

These awards have been made under the Easy Broad Agency Announcement (EZ-BAA) area of interest (AOI) #9: Digital Medical Countermeasures.

This project has been funded in part with Federal funds from HHS/ASPR and BARDA, under Contract No. 75A50122C00034.

Contact Information:

Patricia Zylberman

PR Manager

[email protected]

+5511972447743

Press Release Service
by
Newswire.com

Original Source:

The Covid-19 Detection Foundation (Dba Virufy) and BARDA Announce Contract to Research & Develop Covid-19 Screening Through AI/Machine Learning Technology

BOCA RATON, Fla. – November 10, 2022 – (Newswire.com)

ASP Isotopes Inc. …

NEW HAVEN, Conn. – November 9, 2022 – (Newswire.com)

Amid the wave of se…

ACDIS survey, sponsored by Iodine Software, examines what defines CDI program success, how CDI leaders view their team’s value, and what aspect of their program they would eliminate.

AUSTIN, Texas – November 9, 2022 – (Newswire.com)

Leading enterprise AI software provider Iodine Software today announced a national study of clinical documentation improvement (CDI) leaders that uncovers a number of key insights about how they view their roles and define CDI program success. The survey was conducted by the Association of Clinical Documentation Integrity Specialists (ACDIS) and sponsored by Iodine Software.

CDI programs are a critical component of every healthcare system’s revenue-cycle team, where clinical resources review medical record documentation for completeness and accuracy. 

Accurate and complete documentation is proven to increase earned reimbursement and reduce compliance risks for healthcare systems. If the clinical documentation is incomplete or unclear, CDI specialists query the provider prior to final claim submission to ensure accurate and complete billing, reducing costly and cumbersome issues that can arise during claims adjudication.

Given the ongoing revenue challenges presented by COVID-19 and other market forces, the study was conducted to understand how to best support CDI leaders as they manage their teams. 

The 2022 ACDIS CDI Leadership Council CDI Programmatics survey, which included surveys of 222 CDI leaders, found that nearly all CDI leaders (91%) track financial impact as a measure of departmental success, followed by 68% who use severity of illness (SOI) / risk of mortality (ROM) impact, and 53% who consider the observed-to-expected mortality rate. An additional 28% think observed-to-expected patient length of stay is an important metric that demonstrates CDI program success.

Additional key findings in the study include:

Measuring the Effectiveness of CDI Programs
According to the study, the four most-popular measures that identify CDI program effectiveness are:

• query rate (81%) 
• response rate (79%) 
• review rate (77%) 
• agreement rate (68%)

Most CDI Leaders Feel Valued – But Not All
Eighty-four percent (84%) of CDI leaders report that their program is valued internally by their hospital administrations; however, approximately one in 10 felt undervalued (~11%). In a recent virtual panel discussion, CDI leaders discussed why communicating the value of the CDI team is important. Additionally, these leaders indicated a need to support the CDI team by providing personal feedback to individual team members and department score cards that highlight achieved outcomes.

Optimizing Performance: CDI Leaders’ Challenges to Achieving Top Performance
Respondents to the ACDIS survey reported that the biggest barrier to their CDI team reaching peak performance is a lack of staffing resources (36%), followed by physician engagement challenges (22%) and a lack of technology resources (18%). An additional 9% felt that organization priorities are not aligned properly. 

Staffing challenges have persisted in the CDI profession, as workforce shortages, budget gaps and fierce competition for talent continue to plague the industry. Physician engagement also has historically been a challenge for CDI, because stretched providers often experience significant administrative burdens that result in frustration and burnout. In recent years, physician query and AI-driven CDI tool platforms have played central roles in supporting CDI team performance to drive greater efficiency, reduce workload and drive provider engagement.

Supporting CDI to Work More Efficiently: What CDI Duties Are Most Cumbersome?
While CDI is critical to the financial health of every healthcare system, the role can include extremely tedious tasks that contribute to CDI burnout. In the ACDIS leadership survey, CDI leaders outlined what aspects of the workflow they would eliminate if they could. The number-one responsibility named varied greatly and included, in order:

1. 49%: Wasting time reviewing cases without opportunity
2. 20%: Tracking down physician responses
3. 9%: Working DRG predictions

To help reduce the burdens presented by these and other listed duties, many CDI leaders are implementing in-house and third-party technology solutions that better engage providers and identify a prioritized worklist of cases to review. These CDI tools also leverage new technology that automates and augments clinical human resources and are becoming increasingly important as more work is performed virtually instead of within hospital walls.

“Based on our experience working with nearly 1,000 of the top hospitals in the U.S., Iodine Software deeply understands the market forces affecting the CDI industry, so we know they are under pressure to work more efficiently and capture more earned revenue for a hospital’s bottom line,” said Iodine Software Co-founder and CEO William Chan. “This study reinforces the need for AI-backed solutions that augment the great work that CDI specialists perform every day.”

ACDIS discussed the study’s findings with participants from dozens of provider organizations in September. The full report also is available to download.

About Iodine Software

Iodine is an enterprise AI company that is championing a radical rethink of how to create value for healthcare professionals, leaders, and their organizations: automating complex clinical tasks, generating insights and empowering intelligent care. Iodine’s powerful predictive engine complements the skills and judgment of healthcare professionals by interpreting raw clinical data to generate real-time, highly focused, predictive insights that clinicians and hospital administrators can leverage to dramatically augment the management of care delivery – facilitating critical decisions, scaling clinical workforces through automation, and improving the financial position of health systems. For more information, please visit iodinesoftware.com.

PR Contact: 
[email protected]

Contact Information:

Amanda Wratchford

VP of Marketing

[email protected]

9042522156

Press Release Service
by
Newswire.com

Original Source:

National Study of Clinical Documentation Improvement Leaders Finds Measuring Financial Impact for Their Provider Organization is Most Important Metric of Success

Chike Mocha Mint Protein Iced Coffee is back!

ABILENE, Texas – November 9, 2022 – (Newswire.com)

Many say it’s ‘the most wonderful time of the year’ and Chike Nutrition customers would have to agree. Chike Nutrition is ringing in the holidays and bringing cheer with the return of their most popular and requested seasonal flavor, Chike Mocha Mint Protein Iced Coffee. Although Chike Mocha Mint Protein Iced Coffee is available online starting Nov. 8 and in over 500 locations nationwide, it is sure to sell out quickly.

This flavor is refreshing, balanced and has a true chocolate mint flavor reminding you of that cookie in a silver sleeve. The smell of smooth mint hits first, followed by sweet chocolate notes with mint to balance, and a mid-level sweetness finish. Better yet, each serving is packed with 20 grams of non-GMO whey protein, 150mg of caffeine, and only 1 gram of sugar and 110 calories. A truly healthy option that doesn’t compromise on taste.

A verified purchaser from last year named Heidi left a 5-star review stating, “This is the best flavor I’ve ever had. I need to stock up on 10 more bags since it’s a limited edition flavor!!! I love it!!!!” Clearly, Chike Nutrition’s customers are obsessed with Chike Mocha Mint Protein Iced Coffee.

Chike Mocha Mint Protein Iced Coffee takes the place of your sugary drive-thru coffee and is the ideal breakfast booster, healthy snack, or afternoon pick me-up. If you’re looking for extra holiday cheer, adding Chike Mocha Mint protein coffee powder into recipes easily enhances delicious treats, making them a healthier choice.

“There’s an extra layer of excitement from our customers this holiday season because of the return of our Chike Mocha Mint Protein Iced Coffee. We launched this seasonal flavor for the first time last year and we couldn’t keep up with the demand. Since then, our customers have constantly made requests for it to be a permanent flavor, so much so that we made extra this year! Don’t let an iced coffee drink during the cold weather keep you from trying Chike Mocha Mint Protein Iced Coffee. Grab a bag (or two) while you can and see what all of the hype is about. You won’t be disappointed!”, said Mac Mascorro, Brand Manager of Chike Nutrition.

It’s time to put on your mittens and try this seasonal Protein Iced Coffee that is sure to bring you cheer!

###

About Chike Nutrition

Chike Nutrition is based in Abilene, Texas and proudly manufactures and produces all nine (and counting!) of their current flavors, ensuring the quality and consistency that Chike Nutrition demands in their products. You can find all of the flavors on Chike Nutrition’s website and can follow new recipes, flavor launches, and more on Instagram and Pinterest.  Learn more about Chike in their overview video.

Contact Information:

Mac Mascorro

Brand Manager

[email protected]

Press Release Service
by
Newswire.com

Original Source:

Chike Nutrition is Adding to ‘The Most Wonderful Time of the Year’